Ozempic and similar weight loss drugs, known as GLP-1s, make people less hungry, but they don't seem to stop them from going out to eat.
Bloomberg Businessweek’s Deena Shanker joins Stacey Vanek Smith and Max Chafkin on the Everybody's Business podcast to unpack this new phenomenon and why the weight loss drug craze is actually benefiting the restaurant industry http://bit.ly/46drPxC
Bloomberg Businessweek’s Deena Shanker joins Stacey Vanek Smith and Max Chafkin on the Everybody's Business podcast to unpack this new phenomenon and why the weight loss drug craze is actually benefiting the restaurant industry http://bit.ly/46drPxC